SMAD9 and coronary artery disorder: Similarly, Drake et al. [309] demonstrated that a somatic deletion on chromosome 13, encompassing SMAD9, in PAECs from a patient with PAH associated with CHD could have contributed to the pathogenesis of PAH, and potentially also to CHD [309].